Biochemistry · 2000 · 26 citations · 13 references
Life SciencesBiochemistryMolecular BiologyEnzyme MechanismMolecular VirologyStructural BiologyDna Polymerase FunctionEnzyme InhibitionLigand BindingPolymerase Chain ReactionRna Polymerase FunctionRna Polymerase StructureBackbone Conformational PreferencesDouble-stranded Dna RecognitionDouble-stranded Dna StructureNucleoside Reverse Transcriptase InhibitorsPolymerase Active Site MechanismRibonucleoside ChemistryTernary Complex FormationTernary Compounds
Molecular dynamics simulations of a ternary complex of HIV-1 reverse transcriptase (RT), double-stranded DNA, and bound dideoxynucleoside-5'-triphosphate (RT-DNA-ddNTP), utilizing the ddNTPs ddATP, betaFddATP, and alphaFddATP, explain the experimentally observed order of potency of these 5'-triphosphates as inhibitors of RT: ddATP > betaFddATP > alphaFddATP. On the basis of RT's known preference to bind the incoming dNTP (or ddNTP) with a north conformation at the polymerase site, alphaFddATP, which in solution prefers almost exclusively a north conformation, was predicted to be the most potent inhibitor. However, Tyr115, which appears to function as a steric gate to preclude the binding of ribonucleoside 5'-triphosphates, prevents the effective binding of alphaFddATP in its preferred north conformation. The south-biased betaFddATP, while able to bind to RT without hindrance by Tyr115, has to pay a high energy penalty to be flipped to the active north conformation at the polymerase site. Finally, the more flexible and less conformationally biased ddATP is able to switch to a north conformation at the RT site with a smaller energy penalty than betaFddATP. These results highlight the opposite conformational preferences of HIV-1 RT for alphaFddATP and betaFddATP and help establish conformational guidelines for optimal binding at the polymerase site of this enzyme.
13
Nandanan Erathodiyil, Soo‐Yeon Jang, Stefano Moro et al. · Journal of Medicinal Chemistry · 2000 · 129 citations · Full text